Your Article Summary
See Latest ArticlesThe use of omalizumab in the treatment of severe allergic asthma: A clinical experience update
Respiratory Medicine, 06/30/09
Holgate S et al. - Based on clinical trial data analysis, it is recommended that treatment response is evaluated by the physician after 16 weeks of therapy. Treatment should only be continued in responders, i.e. those judged by the physician to have achieved a marked improvement or complete asthma control. Omalizumab is generally well tolerated. Anaphylactic-like reactions are rare and less common than encountered with other biologics.
Related Articles
Reduced FcεRI-Mediated Release of Asthma-Promoting Cytokines and Chemokines from Human Basophils during Omalizumab Therapy
International Archives of Allergy and Immunology, 10/21/09
Relevance Score: 87%
Relationship between pretreatment specific IgE and the response to omalizumab therapy
Allergy, 11/12/09
Relevance Score: 85%
Effects of omalizumab on markers of inflammation in patients with allergic asthma
Allergy, 11/16/09
Relevance Score: 84%
“Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
Respiratory Medicine, 10/13/09
Relevance Score: 84%
Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthma
Allergy and Asthma Proceedings, 10/12/09
Relevance Score: 83%
Today in Cardiovascular/Pulm...keeping you current
Receive free subspecialty "5-minute updates" via email
Why are some children with early onset of asthma getting better over the years? - Diagnostic failure or salutogenetic factors
International Journal of Medical Sciences , 12/04/09
Effects of PARP-1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: differential effects on CXCR2 ligands and Duffy antigen receptor for chemokines
Journal of Leukocyte Biology, 12/04/09
T-Cell Deficiency in Dual Infection With Cytomegalovirus and Pneumocystis jiroveci Pneumonia
Pediatric Asthma, Allergy & Immunology, 12/04/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Opioid-Like Activity of Naltrexone on Natural Killer Cell Cytolytic Activity and Cytokines Production in Splenocytes: Effects of Alcohol
Journal of Interferon & Cytokine Research, 12/02/09
Impact of chlorhexidine mouth rinse use on postextraction infection via nitric oxide pathway
Inflammation Research, 12/01/09
Efficacy of Short-Course AZT Plus 3TC to Reduce Nevirapine Resistance in the Prevention of Mother-to-Child HIV Transmission: A Randomized Clinical Trial
PLoS Medicine, 11/30/09